IV catheter placement study aims to reduce pain and complications
NCT ID NCT06455228
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 90 patients receiving antibiotics through a long IV catheter. Researchers compared different insertion sites to see which caused fewer problems like phlebitis, bleeding, or infection. The goal is to find the best spot to place the catheter, making treatment more comfortable and reducing complications.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help hospitals choose the best spot for IV catheters in patients on antibiotics, reducing pain and complications.
- What could go wrong
- This is a small, completed study with only 90 participants, so results may not apply to all patients or settings. It does not test a new drug or treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
90 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ① estimated time of intravenous infusion ≥1 week; ② age: ≥18 years; ③ antimicrobial therapy was only used for treatment during hospitalization, with a pH value of 5-9 and osmotic pressure \< 900 mOsm/L; and ④ patients were conscious and able to communicate normally; ⑤ the catheter-to-vessel ratio is less than 45%. Exclusion Criteria: * ① a history of radiotherapy, thrombosis, and trauma at the catheterization site and ② plans to discharge with a catheter during the study duration.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Antimicrobial are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, 310016, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.